Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

NCT02942329 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Hepatocellular Carcinoma

Interventions

DRUG: apatinib
DRUG: SHR-1210

Sponsor

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences